Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Amarin Shares Crushed After Judge Rules Heart Drug Patents Invalid: Report
By Tom Bemis
Mar 30, 2020 6:37 PM EDT
PRESS RELEASES
Grifols 2020 Annual Report On Form 20-F Filed With The SEC On April 9, 2021
By PR Newswire
Apr 9, 2021 10:30 AM EDT
PRESS RELEASES
Grifols Announces Topline Data From NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Hyperimmune Globulins As A Treatment For Hospitalized Patients With COVID-19
By PR Newswire
Apr 2, 2021 11:18 AM EDT
PRESS RELEASES
Grifols Reinforces Its Innovation Strategy After Completing The Acquisition Of GigaGen To Boost A Novel Method To Generate A Wide Range Of Immunoglobulins
By PR Newswire
Mar 9, 2021 3:15 AM EST
PRESS RELEASES
Grifols PharmacyKeeper Ranked No. 1 As 'Best In KLAS' For Fifth Consecutive Year
By PR Newswire
Feb 23, 2021 9:00 AM EST
PRESS RELEASES
Grifols Begins Clinical Trial Of A New Treatment That Would Provide Immediate Immunity Against COVID-19
By PR Newswire
Jan 18, 2021 6:00 AM EST
PRESS RELEASES
The Dow Jones Sustainability Index Recognizes Grifols As One Of The World's Most Sustainable Companies
By PR Newswire
Nov 16, 2020 9:14 AM EST
PRESS RELEASES
Grifols Partners With TRC Healthcare To Streamline Intravenous Compounding Education
By PR Newswire
Nov 12, 2020 9:00 AM EST
PRESS RELEASES
Grifols' Anti-SARS-CoV-2 Hyperimmune Globulin Begins Clinical Trial In Patients With COVID-19
By PR Newswire
Oct 9, 2020 6:23 AM EDT
PRESS RELEASES
Grifols Closes The Acquisition Of Green Cross Fractionation Plant In Canada And 11 Plasma Centers In The U.S.
By PR Newswire
Oct 1, 2020 12:13 PM EDT
PRESS RELEASES
Grifols To Acquire Alkahest To Enhance Discovery Research And Development To Identify Innovative Therapies For Age-related Diseases Based Upon An Understanding Of The Human Plasma Proteome
By PR Newswire
Sep 7, 2020 2:50 AM EDT
PRESS RELEASES
ICU Medical Broadens Its Non-PVC/Non-DEHP IV Solutions Portfolio By Entering Long-Term U.S. Distribution Agreement With Grifols For Certain Core IV Solution Products
By PR Newswire
Aug 10, 2020 4:00 PM EDT
PRESS RELEASES
Grifols Delivers First Manufactured Batches Of Its Anti-SARS-CoV-2 Hyperimmune Globulin For Clinical Trials
By PR Newswire
Jul 28, 2020 10:41 AM EDT
PRESS RELEASES
Results Of Grifols' AMBAR Clinical Trial Published In Alzheimer's & Dementia: The Journal Of The Alzheimer's Association
By PR Newswire
Jul 27, 2020 1:18 PM EDT
PRESS RELEASES
Grifols To Acquire Green Cross Plasma Fractionation Facility In Montreal And A Plasma Collection Organization In The U.S. For US$460 Million
By PR Newswire
Jul 20, 2020 2:39 AM EDT
PRESS RELEASES
Rigel Announces Availability Of TAVLESSE® (Fostamatinib Disodium Hexahydrate) In Europe
By PR Newswire
Jul 9, 2020 8:19 AM EDT
PRESS RELEASES
Grifols Starts Production Of Its Hyperimmune Immunoglobulin As A Potential Passive Immune Therapy Against COVID-19
By PR Newswire
Jun 11, 2020 4:03 AM EDT
PRESS RELEASES
Racing Against Time, Medical Researchers, Life Science Companies And COVID-19 Survivors Launch National Campaign To Drive Blood Plasma Donation
By PR Newswire
May 26, 2020 9:00 AM EDT
PRESS RELEASES
Grifols Procleix Panther System With Automation Ready Technology (ART) Receives FDA Approval
By PR Newswire
May 7, 2020 9:00 AM EDT
PRESS RELEASES
Grifols Launches New 3-mL (900-IU) Vial For High-potency HyperRAB® (rabies Immune Globulin [human])
By PR Newswire
Apr 28, 2020 9:00 AM EDT
PRESS RELEASES
Grifols 2019 Annual Report On Form 20-F Filed With The SEC On April 6, 2020
By PR Newswire
Apr 6, 2020 9:30 AM EDT
INVESTING
Amarin Shares Crushed After Judge Rules Heart Drug Patents Invalid: Report
By Tom Bemis
Mar 30, 2020 6:37 PM EDT
PRESS RELEASES
Grifols PharmacyKeeper Ranked No. 1 In KLAS Rating, Extends Category Leadership
By PR Newswire
Feb 13, 2020 9:00 AM EST
MERGERS AND ACQUISITIONS
Hologic agrees to sell blood screening business to Grifols for $1.7B
By Bill Meagher
Dec 14, 2016 7:14 PM EST
OPINION
5 big dividend stocks John Paulson loves
By Emily Stewart
Sep 8, 2016 7:39 AM EDT
